Your browser version may not work well with NCBI's Web applications. More information here...
1: Cancer Cell. 2002 Aug;2(2):103-12.Click here to read Links

The RB and p53 pathways in cancer.

Sherr CJ, McCormick F.

Howard Hughes Medical Institute, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. sherr@stjude.org

The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) and the p53 transcription factor. Here, we discuss interconnecting signaling pathways controlled by RB and p53, attempting to explain their potentially universal involvement in the etiology of cancer. Pinpointing the various ways by which the functions of RB and p53 are subverted in individual tumors should provide a rational basis for developing more refined tumor-specific therapies.

PMID: 12204530 [PubMed - indexed for MEDLINE]

Recent Activity